| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 144.319 | 155.184 | 136.449 | 167.811 | 193.218 | 57.337 | 280.662 | 437.139 | - | - |
| Total Income - EUR | 144.340 | 155.692 | 137.052 | 168.224 | 194.023 | 59.829 | 281.938 | 441.377 | - | - |
| Total Expenses - EUR | 142.178 | 143.544 | 130.047 | 159.307 | 190.962 | 187.898 | 259.592 | 429.303 | - | - |
| Gross Profit/Loss - EUR | 2.161 | 12.148 | 7.005 | 8.918 | 3.061 | -128.069 | 22.347 | 12.074 | - | - |
| Net Profit/Loss - EUR | 1.632 | 10.137 | 4.083 | 7.239 | 1.131 | -128.448 | 19.530 | 7.666 | - | - |
| Employees | 4 | 5 | 4 | 3 | 3 | 3 | 2 | 3 | - | - |
Check the financial reports for the company - Clinicile Dr. Eidelman S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 22.900 | 19.951 | 29.969 | 29.018 | 170.759 | 150.421 | 117.131 | 97.759 | - | - |
| Current Assets | 5.058 | 5.109 | 19.214 | 21.153 | 34.504 | 47.363 | 68.579 | 101.128 | - | - |
| Inventories | 807 | 896 | 8.785 | 2.413 | 27.649 | 34.598 | 24.915 | 46.856 | - | - |
| Receivables | 2.212 | 2.669 | 3.953 | 13.422 | 1.786 | 1.511 | 30.512 | 49.923 | - | - |
| Cash | 2.038 | 1.543 | 6.477 | 5.318 | 5.069 | 11.254 | 13.151 | 4.349 | - | - |
| Shareholders Funds | 20.885 | 17.448 | 12.718 | 11.299 | 1.232 | -127.239 | -104.887 | -97.995 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 7.895 | 8.233 | 35.368 | 38.629 | 207.818 | 324.734 | 291.509 | 297.112 | - | - |
| Income in Advance | 0 | 1.685 | 1.284 | 895 | 538 | 399 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Clinicile Dr. Eidelman S.r.l.